About this data
What it is
When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
Who files it
The insider, usually through the company, within two business days of the trade.
How current
We collect new filings throughout the day on SEC business days.
Worth knowing
Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.

All of this comes from public filings.

Open-market trades per day, last 30 days

05001,000Oct 18 · Purchases: 0Oct 18 · Sales: 0Oct 18Oct 19 · Purchases: 29Oct 19 · Sales: 159Oct 20 · Purchases: 45Oct 20 · Sales: 209Oct 21 · Purchases: 38Oct 21 · Sales: 183Oct 22 · Purchases: 50Oct 22 · Sales: 130Oct 22Oct 23 · Purchases: 77Oct 23 · Sales: 126Oct 24 · Purchases: 1Oct 24 · Sales: 0Oct 25 · Purchases: 0Oct 25 · Sales: 0Oct 26 · Purchases: 60Oct 26 · Sales: 171Oct 26Oct 27 · Purchases: 27Oct 27 · Sales: 217Oct 28 · Purchases: 44Oct 28 · Sales: 135Oct 29 · Purchases: 35Oct 29 · Sales: 199Oct 30 · Purchases: 68Oct 30 · Sales: 270Oct 30Oct 31 · Purchases: 3Oct 31 · Sales: 0Nov 1 · Purchases: 2Nov 1 · Sales: 0Nov 2 · Purchases: 79Nov 2 · Sales: 826Nov 3 · Purchases: 66Nov 3 · Sales: 337Nov 3Nov 4 · Purchases: 67Nov 4 · Sales: 535Nov 5 · Purchases: 108Nov 5 · Sales: 458Nov 6 · Purchases: 137Nov 6 · Sales: 390Nov 7 · Purchases: 0Nov 7 · Sales: 0Nov 7Nov 8 · Purchases: 0Nov 8 · Sales: 0Nov 9 · Purchases: 110Nov 9 · Sales: 457Nov 10 · Purchases: 97Nov 10 · Sales: 406Nov 11 · Purchases: 98Nov 11 · Sales: 330Nov 11Nov 12 · Purchases: 54Nov 12 · Sales: 167Nov 13 · Purchases: 23Nov 13 · Sales: 28Nov 14 · Purchases: 0Nov 14 · Sales: 0Nov 15 · Purchases: 0Nov 15 · Sales: 0Nov 15Nov 16 · Purchases: 0Nov 16 · Sales: 0
05001,000Oct 18 · Purchases: 0Oct 18 · Sales: 0Oct 18Oct 19 · Purchases: 29Oct 19 · Sales: 159Oct 20 · Purchases: 45Oct 20 · Sales: 209Oct 21 · Purchases: 38Oct 21 · Sales: 183Oct 22 · Purchases: 50Oct 22 · Sales: 130Oct 22Oct 23 · Purchases: 77Oct 23 · Sales: 126Oct 24 · Purchases: 1Oct 24 · Sales: 0Oct 25 · Purchases: 0Oct 25 · Sales: 0Oct 26 · Purchases: 60Oct 26 · Sales: 171Oct 26Oct 27 · Purchases: 27Oct 27 · Sales: 217Oct 28 · Purchases: 44Oct 28 · Sales: 135Oct 29 · Purchases: 35Oct 29 · Sales: 199Oct 30 · Purchases: 68Oct 30 · Sales: 270Oct 30Oct 31 · Purchases: 3Oct 31 · Sales: 0Nov 1 · Purchases: 2Nov 1 · Sales: 0Nov 2 · Purchases: 79Nov 2 · Sales: 826Nov 3 · Purchases: 66Nov 3 · Sales: 337Nov 3Nov 4 · Purchases: 67Nov 4 · Sales: 535Nov 5 · Purchases: 108Nov 5 · Sales: 458Nov 6 · Purchases: 137Nov 6 · Sales: 390Nov 7 · Purchases: 0Nov 7 · Sales: 0Nov 7Nov 8 · Purchases: 0Nov 8 · Sales: 0Nov 9 · Purchases: 110Nov 9 · Sales: 457Nov 10 · Purchases: 97Nov 10 · Sales: 406Nov 11 · Purchases: 98Nov 11 · Sales: 330Nov 11Nov 12 · Purchases: 54Nov 12 · Sales: 167Nov 13 · Purchases: 23Nov 13 · Sales: 28Nov 14 · Purchases: 0Nov 14 · Sales: 0Nov 15 · Purchases: 0Nov 15 · Sales: 0Nov 15Nov 16 · Purchases: 0Nov 16 · Sales: 0

Purchases Sales

By trade date. Insiders have two business days to file, so the most recent days fill in later.

Latest open-market insider trades

Reset

Showing: ticker OXBR

Latest open-market insider trades
TradedInsiderCompanyTypeSharesPriceValueFiling
Sep 16, 2025Allan S. Martin
10% owner
OXBR
Oxbridge Re Holdings Limited
Sale4,328$2.45$10.6K SaleForm 4 ↗
Aug 27, 2025Allan S. Martin
10% owner
OXBR
Oxbridge Re Holdings Limited
Sale6,551$2.38$15.6K SaleForm 4 ↗
Aug 27, 2025Allan S. Martin
10% owner
OXBR
Oxbridge Re Holdings Limited
Sale3,449$2.39$8,243 SaleForm 4 ↗
Jul 24, 2025Allan S. Martin
10% owner
OXBR
Oxbridge Re Holdings Limited
Sale2,000$2.43$4,860 SaleForm 4 ↗
Jul 23, 2025Allan S. Martin
10% owner
OXBR
Oxbridge Re Holdings Limited
Sale2,000$2.38$4,760 SaleForm 4 ↗
Jul 22, 2025Allan S. Martin
10% owner
OXBR
Oxbridge Re Holdings Limited
Sale1,000$2.40$2,400 SaleForm 4 ↗
Jul 18, 2025Allan S. Martin
10% owner
OXBR
Oxbridge Re Holdings Limited
Sale2,000$2.31$4,620 SaleForm 4 ↗
Jul 17, 2025Allan S. Martin
10% owner
OXBR
Oxbridge Re Holdings Limited
Sale1,000$2.27$2,270 SaleForm 4 ↗
Jul 14, 2025Allan S. Martin
10% owner
OXBR
Oxbridge Re Holdings Limited
Sale2,000$2.45$4,900 SaleForm 4 ↗
Jul 11, 2025Allan S. Martin
10% owner
OXBR
Oxbridge Re Holdings Limited
Sale2,000$2.22$4,440 SaleForm 4 ↗
Jul 10, 2025Allan S. Martin
10% owner
OXBR
Oxbridge Re Holdings Limited
Sale1,000$2.07$2,070 SaleForm 4 ↗
Jul 9, 2025Allan S. Martin
10% owner
OXBR
Oxbridge Re Holdings Limited
Sale500$2.11$1,055 SaleForm 4 ↗
Jul 9, 2025Allan S. Martin
10% owner
OXBR
Oxbridge Re Holdings Limited
Sale500$2.06$1,030 SaleForm 4 ↗
Jul 7, 2025Allan S. Martin
10% owner
OXBR
Oxbridge Re Holdings Limited
Sale1,000$1.94$1,940 SaleForm 4/A ↗
May 27, 2025Sanjay Madhu
CEO, President, Director
OXBR
Oxbridge Re Holdings Limited
Buy22,500$1.86$41.9K BuyForm 4 ↗
May 15, 2025Sanjay Madhu
CEO, President, Director
OXBR
Oxbridge Re Holdings Limited
Buy25,000$2.10$52.5K BuyForm 4 ↗
Oct 17, 2024Allan S. Martin
10% owner
OXBR
Oxbridge Re Holdings Limited
Sale7,574$3.00$22.7K SaleForm 4 ↗

17 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 16, 2026, 12:42 AM EST.

Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.

Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances